Over-expression of VEGF-C in the tumour micro-environment has been reported to be associated with a poor prognosis (Nakamura et al, 2003; Mylona et al, 2007) and lymph node metastasis (Nakamura et al, 2005) in breast cancer patients. Here, VEGFC is linked to neoplasm.